| Literature DB >> 22930338 |
Jette Kjeldgaard1, Marianne T Cohn, Pat G Casey, Colin Hill, Hanne Ingmer.
Abstract
UNLABELLED: Fermented sausages, although presumed safe for consumption, sometimes cause serious bacterial infections in humans that may be deadly. Not much is known about why and when this is the case. We tested the hypothesis that residual veterinary antibiotics in meat can disrupt the fermentation process, giving pathogenic bacteria a chance to survive and multiply. We found that six commercially available starter cultures were susceptible to commonly used antibiotics, namely, oxytetracycline, penicillin, and erythromycin. In meat, statutorily tolerable levels of oxytetracycline and erythromycin inhibited fermentation performance of three and five of the six starter cultures, respectively. In model sausages, the disruption of meat fermentation enhanced survival of the pathogens Escherichia coli O157:H7 and Salmonella enterica serovar Typhimurium compared to successful fermentations. Our work reveals an overlooked risk associated with the presence of veterinary drugs in meat. IMPORTANCE: Antibiotics have for a long time been used as growth promoters in farm animals, and while they are banned as such in Europe, their clinical use in farm animals still accounts for the majority of consumption. Here, we examined how acceptable levels of antibiotics in meat influence fermentation. Our results show that commonly used bacterial starter cultures are sensitive to residual antibiotics at or near statutorily tolerable levels, and as a result, processed sausages may indeed contain high levels of pathogens. Our findings provide a possible explanation for outbreaks and disease cases associated with consumption of fermented sausages and offer yet another argument for limiting the use of antimicrobials in farm animals.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22930338 PMCID: PMC3445968 DOI: 10.1128/mBio.00190-12
Source DB: PubMed Journal: MBio Impact factor: 7.867
FIG 1 Impact of residual antibiotic concentrations on starter culture growth and acid production. Six commercial starter cultures were inoculated in MRS broth (Oxoid) at an absorbance at 600 nm of 0.05 in the presence or absence of oxytetracycline (A), erythromycin (B), or penicillin (C). After incubation at 25°C for 20 h, absorbance (bars) and pH (dots) were measured. Arrows mark the tolerance levels (TL, set by the FDA) for residual tetracyclines (2 µg ml−1) or the maximal residual limits (MRL, set by the EU) for penicillin (0.05 µg ml−1) and erythromycin (0.2 µg ml−1). Color intensities indicate antibiotic concentrations.
FIG 2 Residual antibiotic impact on pathogen survival and fermentation. (A) Bioluminescent imaging after 48 h of fermentation at 25°C on triplicate 1-g sausage samples inoculated with the E. coli O157:H7 reporter strain without (lower row) and with (upper row) the addition of erythromycin (0.4 µg g−1). The color bar indicates bioluminescence signal intensity (in photons s−1 cm−2). (B) Selective E. coli O157:H7 and (C) S. Typhimurium counts (bars) and relative light units (RLU; dots) in model sausages after fermentation (48 h, 25°C). Each bar or dot shows the value for one representative of three biological replicates, measured in three technical replications. Erm, erythromycin (0.4 µg g−1); oTet, oxytetracycline (2.0 µg g−1). Starting counts before fermentation were 2.9 × 107 to 3.3 × 107 CFU g−1 for E. coli and 1.7 × 107 to 2.5 × 107 CFU g−1 for S. Typhimurium.